SuperworthP3 Health Partners market cap PIII
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $30.1M
- Highest close in our data
- $74.1B
- Jun 2023
P3 Health Partners is worth $30.1M at the close on Oct 23, 2026, at $4.14 a share.
That is down 53% over the last year and down 100% over five years.
Its highest close in our data was $74.1B in Jun 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $30.1M | $13.8M | $95.6M | +17% |
| 2025 | $25.7M | $25.7M | $4.4B | −99% |
| 2024 | $3.6B | $3.5B | $20.5B | −84% |
| 2023 | $22.1B | $9.7B | $74.1B | −2% |
| 2022 | $22.4B | $7.6B | $66.1B | +58% |
| 2021 | $14.2B | $14.2B | $23.1B | n/a |
Against its peers
Companies in Healthcare nearest P3 Health Partners' size, closest first, today.
| Company | Market cap |
|---|---|
| PIIIP3 Health Partners | $30.1M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on P3 Health Partners
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.